Navigation Links
European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors
Date:3/5/2009

Schering-Plough Receives EU and US Approvals for Intravenous Formulation of Temozolomide As Well As EU Approval for Oral Temozolomide Sachet Presentation

KENILWORTH, N.J., March 5 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced that the European Commission and the US FDA both approved the intravenous (IV) formulation of temozolomide as an alternative to the already approved oral form of the drug. Temozolomide is marketed as TEMODAL(R) in the EU and as TEMODAR(R) in the US. The EU Commission Decision was based on the positive opinion from the European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) in November 2008. On January 22, 2009, the Commission approved a sachet packaging presentation for TEMODAL Capsules. This new presentation provides greater patient convenience and flexibility. On February 17, 2009, the Commission approved an IV formulation of TEMODAL. On February 27, 2009, Schering-Plough received approval from the US FDA for the TEMODAR IV formulation.

TEMODAL is a chemotherapy agent approved in the EU for treatment of patients with newly diagnosed glioblastoma multiforme (GBM) concomitantly with radiotherapy and subsequently as monotherapy, and for patients with malignant gliomas, such as GBM or anaplastic astrocytoma (AA), showing recurrence or progression after standard therapy. In the US, TEMODAR is approved for the treatment of adult patients with newly diagnosed GBM concomitantly with radiotherapy and then as maintenance treatment, as well as for refractory AA, i.e., patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine.

"TEMODAR is a well recognized, effective treatment for patients with newly diagnosed GBM. The newly approved IV formulation of TEMODAR provides
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. CorMatrix Cardiovascular Announces First European Implants of CorMatrix(R) ECM Technology(TM)
2. Winner Medical Receives European Patent Office Approval for PurCotton(TM) Production Method
3. Frost & Sullivan: Novel Diagnostics Methods Driving the European Cancer IVD Market Towards Early Detection and Prevention
4. Abbott Receives European Commission Clearance on Acquisition of Advanced Medical Optics
5. Eisai and Bial Announce Partnership Agreement for the European Commercialisation of the Novel Once Daily Anti-Epileptic Zebinix(R)
6. Rising Demand and Government Backing Fuel European Document Management Systems Market
7. Noteworthy Medical Systems, Inc. Secures Capital from Top European eHealth Provider and Closes on Merger with Strategic Partner
8. ECO 2009 -- The 17th European Congress on obesity
9. PAREXEL Consulting Enhances European Regulatory Affairs Capabilities With Appointment of Medical Products Agency Expert Dr. Anders Neil
10. Global Economic Meltdown - Is the European Cardiac Rhythm Management Market Spared?
11. BeneChill Launches European Study of Intra-Arrest Cooling
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Principle Business Enterprises, a family owned ... top-of-the-line absorbent products. The company has recently made ... brand, Tranquility® Premium Protection absorbent products. The company ... its packaging a new look, and is currently working ... the public. , The new website, developed with Thread ...
(Date:10/20/2014)... Collins, CO (PRWEB) October 20, 2014 ... dGH assays are the only imaging assays capable ... in a single test.  With these three dimensions ... their ability to detect the widest range of ... translocations—mutations usually missed by other genomic tools, including ...
(Date:10/20/2014)... 20, 2014 Punzoné , the first ... U.S., has a lot to celebrate this month. October marks ... the achievements and contributions of Americans of Italian heritage and ... and today it shares its favorite Italian cocktails and encourages ... Italy - even if it is only in a glass. ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 Recently, BambooIndustry.com, ... has unveiled its new range of bamboo deckings ... for these natural items; they are now available at ... most people, it is hard to overstate the significance ... of attention to online services. The company’s workers are ...
(Date:10/19/2014)... 20, 2014 Recently, Fancyflyingfox.com, an innovative ... clothes, has announced its latest designs of 2014 ... the new elegant outfits are offered with big discounts, ... order before October 30 can enjoy this special offer. ... marketing strategies, it has become one of the leading ...
Breaking Medicine News(10 mins):Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 3Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 4Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2Health News:Fancyflyingfox.com Updates Its Website With New Mother Of The Bride Dresses For 2014 2
... order to provide quick relief from post pregnancy depressions, health ... more vulnerable to this type of depression and taken preventive ... the researcher of University of Toronto, Canada who had reviewed ... it is possible to prevent post partum depression but the ...
... twins may be more different from each other than that ... lost over the time that can leave them very different ... in identical twins is the direct result of their epigenome. ... because of its genetic structure, but because of the varied ...
... two human clinical trials support the enhanced bioavailability// ... which will interest manufacturers of CoQ10 products. ... ingredient, allows supplement and food makers to use lower ... technology uses common food-grade emulsifiers and solvents to trap ...
... may play a more dominant role than exercise// for increasing bad ... why some people never gain weight or increase their cholesterol despite ... content!! , ,The July 8, 2005, issue of the ... pairs of identical twins in whom one was a vigorous exerciser ...
... are often treated with inhaled nitric oxide// therapy. A recent ... not reduce the chances of death or further lung infections. ... babies who weigh less than 1.5kgs need not be given ... a study. Inhaled nitric oxide therapy is effective for treating ...
... Nervosa is a condition that usually affects young women and ... is due to overactive dopamine receptors in the basal ganglia ... are driven to be excessively thin and are unaware of ... many will remember the death of the famous talented singer ...
Cached Medicine News:Health News:Genes More Important Than Exercise for Bad Cholesterol 2Health News:PET Scan find the Area of Brain Responsible for Anorexia Nervosa 2Health News:PET Scan find the Area of Brain Responsible for Anorexia Nervosa 3
(Date:10/20/2014)... and RALEIGH, N.C., Oct. 20, 2014  BioPontis ... Foundation (HNF), both philanthropies, announced today the creation ... for the treatment of the rare disease known ... Alliance announced its alliance model earlier this month. ... demonstration of a collaborative model where researchers and ...
(Date:10/18/2014)... Oct. 18, 2014  In a policy ... (HRC), the nation,s largest lesbian, gay, bisexual and ... use of Truvada for Pre-Exposure Prophylaxis (PrEP). PrEP ... to prevent the spread of a disease or ... brand name anti-HIV drug combination currently approved for ...
(Date:10/17/2014)... Conn. , Oct. 17, 2014 UBM Medica ... a leading online community and information resource for neurologists ... disease and Alzheimer disease , with discussions of ... to 1 million Americans have Parkinson disease , more ... dystrophy, or Lou Gehrig disease. Diagnosis can be ...
Breaking Medicine Technology:The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 2The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 3HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 2HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 3Neurology Times Features Coverage of Parkinson and Alzheimer Disease 2Neurology Times Features Coverage of Parkinson and Alzheimer Disease 3
... May 11, 2011 Reportlinker.com announces ... is available in its catalogue: ... 2011 – Generics Market Overview: Patent ... uptake despite tougher market conditions ...
... Daiichi Sankyo announced that applications have been submitted ... of metastatic melanoma to the U.S. Food and Drug ... a pre-marketing application for approval for a companion diagnostic ... also will be registered in Europe.  Vemurafenib is an ...
Cached Medicine Technology:Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions 2Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions 3Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions 4Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions 5Vemurafenib New Drug Application Submitted to FDA for Melanoma 2Vemurafenib New Drug Application Submitted to FDA for Melanoma 3Vemurafenib New Drug Application Submitted to FDA for Melanoma 4
For regulating sample flow rate when using the QIAvac 24 Plus;...
Holder for QIAGEN 96-well plates, for use with QIAvac 96;...
For connecting the QIAvac 24 Plus and Vacuum Pump;...
For monitoring vacuum pressure, suitable for use with all QIAvac manifolds;...
Medicine Products: